NCT00150202 - Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

October 31, 2006

Conditions

Macular Degeneration

Interventions

DRUG

pegaptanib sodium

Trial Locations (14)

Pfizer Investigational Site, Nagoya

Pfizer Investigational Site, Urayasu-shi

Pfizer Investigational Site, Tokyo

Pfizer Investigational Site, Fukuoka

Pfizer Investigational Site, Fukushima

Pfizer Investigational Site, Maebashi

Pfizer Investigational Site, Sapporo

Pfizer Investigational Site, Kida-gun

Pfizer Investigational Site, Kyoto

Pfizer Investigational Site, Moriguchi

Pfizer Investigational Site, Suita

Pfizer Investigational Site, Ōtsu

Pfizer Investigational Site, Mitaka

Pfizer Investigational Site, Shinjuku-ku